Dihydrocodeine Bitartrate And Aspirin And Caffeine
NDC Package 57902-419-88

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Dihydrocodeine Bitartrate And Aspirin And Caffeine is a . Marketed by Eusa Pharma (usa), Inc., this product is identified by NDC 57902-419 and is authorized under FDA application NDA011483.

Identification & Billing

NDC Package Code
57902-419-88
Package Description
100 CAPSULE in 1 BOTTLE
Product Code
57902-419
11-Digit Billing Format
57902041988

Clinical Specifications

Proprietary Name
Dihydrocodeine Bitartrate And Aspirin And Caffeine DC
Dosage Form
-

Regulatory & Marketing

Labeler Name
Eusa Pharma (usa), Inc.
FDA Application #
NDA011483
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-25-2011
End Marketing Date
12-31-2012
Listing Expiration
12-31-2012
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 57902-419-88 identifies a specific commercial package of 100 capsule in 1 bottle of Dihydrocodeine Bitartrate And Aspirin And Caffeine DC, labeled by Eusa Pharma (usa), Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Eusa Pharma (usa), Inc. on April 25, 2011. The current certification is valid through December 31, 2012.

How is this Eusa Pharma (usa), Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 57902041988. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
57902-419-88
11-Digit CMS (5-4-2)
57902-0419-88

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.